Health ❯Medicine

Neurology

Neurology Clinical Trials Neuroscience Research Drug Development Medical Research Cell Biology Clinical Trials Neurology Genetics

3 ARTICLES

yesterday

HIV Drugs Linked to Lower Alzheimer’s Risk, Prompting Calls for Clinical Trials

New research suggests nucleoside reverse transcriptase inhibitors may reduce Alzheimer’s risk by up to 13% annually, with trials planned to confirm their potential and test a safer derivative drug.

3 ARTICLES

yesterday

Living Human Brain Tissue Provides Breakthrough Insights Into Alzheimer’s Disease

6 ARTICLES

last mo.

Blood Test Advances Alzheimer’s Diagnosis and Staging with 92% Accuracy

3 ARTICLES

last mo.

Experimental Drug Shows Potential to Delay Alzheimer's Onset by 50%

8 ARTICLES

last mo.

Study Suggests Long-Term Anti-Amyloid Therapy May Delay Early-Onset Alzheimer’s

Neurology

HIV Drugs Linked to Lower Alzheimer’s Risk, Prompting Calls for Clinical Trials

Migraine Drug Ubrogepant Found to Ease Early Symptoms Before Headache Onset

New Genetic Model Predicts Early-Onset Alzheimer’s Risk and Delays

Researchers Identify ZIP4–TREM1 Axis as Key Driver of Glioblastoma Growth

Psilocybin Pilot Study Shows Weeks-Long Symptom Relief in Parkinson’s Patients

Living Human Brain Tissue Provides Breakthrough Insights Into Alzheimer’s Disease

Blood Test Advances Alzheimer’s Diagnosis and Staging with 92% Accuracy

Experimental Drug Shows Potential to Delay Alzheimer's Onset by 50%

Study Suggests Long-Term Anti-Amyloid Therapy May Delay Early-Onset Alzheimer’s